| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2028* | 2021 |
| Intravenous iron in patients undergoing maintenance hemodialysis IC Macdougall, C White, SD Anker, S Bhandari, K Farrington, PA Kalra, ... New England Journal of Medicine 380 (5), 447-458, 2019 | 457 | 2019 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 419 | 2010 |
| Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CM Clase, JJ Carrero, DH Ellison, ME Grams, BR Hemmelgarn, ... Kidney international 97 (1), 42-61, 2020 | 395 | 2020 |
| Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease A Mikhail, C Brown, JA Williams, V Mathrani, R Shrivastava, J Evans, ... BMC nephrology 18, 1-29, 2017 | 336 | 2017 |
| Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis R de Silva, NP Nikitin, KKA Witte, AS Rigby, K Goode, S Bhandari, ... European heart journal 27 (5), 569-581, 2006 | 316 | 2006 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 260 | 2016 |
| Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone … P Rossignol, JGF Cleland, S Bhandari, S Tala, F Gustafsson, R Fay, ... Circulation 125 (2), 271-279, 2012 | 192 | 2012 |
| Anemia, renal dysfunction, and their interaction in patients with chronic heart failure R de Silva, AS Rigby, KKA Witte, NP Nikitin, L Tin, K Goode, S Bhandari, ... The American journal of cardiology 98 (3), 391-398, 2006 | 191 | 2006 |
| Daprodustat for the treatment of anemia in patients not undergoing dialysis AK Singh, K Carroll, JJV McMurray, S Solomon, V Jha, KL Johansen, ... New England Journal of Medicine 385 (25), 2313-2324, 2021 | 185 | 2021 |
| Renin–angiotensin system inhibition in advanced chronic kidney disease S Bhandari, S Mehta, A Khwaja, JGF Cleland, N Ives, E Brettell, ... New England Journal of Medicine 387 (22), 2021-2032, 2022 | 182 | 2022 |
| Daprodustat for the treatment of anemia in patients undergoing dialysis AK Singh, K Carroll, V Perkovic, S Solomon, V Jha, KL Johansen New England Journal of Medicine 385 (25), 2325-2335, 2021 | 179 | 2021 |
| The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease JM Ng, M Cooke, S Bhandari, SL Atkin, ES Kilpatrick Diabetes care 33 (11), 2310-2313, 2010 | 175 | 2010 |
| Survivors of acute renal failure who do not recover renal function S Bhandari, JH Turney QJM: An International Journal of Medicine 89 (6), 415-422, 1996 | 167 | 1996 |
| Current misconceptions in diagnosis and management of iron deficiency M Muñoz, S Gómez-Ramírez, M Besser, J Pavía, F Gomollón, ... Blood Transfusion 15 (5), 422, 2017 | 166 | 2017 |
| A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia S Fishbane, M Ford, M Fukagawa, K McCafferty, A Rastogi, B Spinowitz, ... Journal of the American Society of Nephrology 30 (9), 1723-1733, 2019 | 156 | 2019 |
| Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial S Bhandari, N Ives, EA Brettell, M Valente, P Cockwell, PS Topham, ... Nephrology Dialysis Transplantation 31 (2), 255-261, 2016 | 153 | 2016 |
| State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease W Reinisch, M Staun, S Bhandari, M Muñoz Journal of Crohn's and Colitis 7 (6), 429-440, 2013 | 128 | 2013 |
| Cardiac involvement in Wegener's granulomatosis. NE Goodfield, S Bhandari, WD Plant, A Morley-Davies, GR Sutherland Heart 73 (2), 110-115, 1995 | 114 | 1995 |
| Biomarkers of tolerance in kidney transplantation: are we predicting tolerance or response to immunosuppressive treatment? I Rebollo-Mesa, E Nova-Lamperti, P Mobillo, M Runglall, S Christakoudi, ... American Journal of Transplantation 16 (12), 3443-3457, 2016 | 112 | 2016 |
Philip KalraProfessor of Nephrology, Salford Royal and University of ManchesterVerified email at manchester.ac.uk